Regular purchasing channels and purchasing suggestions for Telisotuzumab

Telisotuzumab (Telisotuzumab vedotin) is an experimental antibody drug conjugate (ADC) that mainly targets c-MET The receptor is being used to treat various solid tumors such as non-small cell lung cancer (NSCLC) with abnormal expression of c-MET. Since it has not yet been officially approved for marketing in mainland China, patients who need medication usually need to obtain it through overseas channels.

Currently, some compliant medical service institutions or cross-border pharmaceutical service platforms in China (such as third-party pharmaceutical service companies with medical qualification certification) provide overseas new drug acquisition services. These platforms usually cooperate with foreign pharmacies, pharmaceutical companies or medical institutions to help patients legally obtain new drugs that have not yet been launched in China, including terituzumab. When choosing a platform, you should confirm whether it has medical consulting qualifications, whether it provides doctor prescription evaluation, drug transportation compliance and other factors to protect drug quality and personal rights and interests.

Patients can also go to hospitals in countries where the drug has been marketed (such as the United States, Japan or parts of the European Union) for diagnosis and treatment, and purchase terituzumab at local legal pharmacies after receiving a prescription from the attending doctor. The advantage of this method is that complete medical evaluation and treatment guidance can be obtained, but the cost is higher, and the time and procedures are more complicated. Some patients also obtain prescriptions through overseas remote consultation platforms and have their medicines mailed to them by designated pharmacies.

There are many so-called illegal or gray channels on the Internet such as "overseas purchasing agents" and "personal agents", which may involve risks such as smuggled drugs, counterfeit drugs, improper storage and transportation, etc., and can easily lead to ineffective medication or even serious adverse reactions for patients. Terituzumab is a biopharmaceutical that highly relies on cold chain transportation and batch control. Any transportation or unknown source may affect the stability of the drug. Therefore, it is strongly recommended to avoid purchasing through personal purchasing agents or unknown institutions on social platforms.

Before deciding to use terituzumab, be sure to conduct professional genetic testing (such as c-METexpression/amplification) to determine whether you belong to the potentially suitable population. In addition, you should evaluate your own condition and risks and establish a treatment and monitoring plan under the guidance of a specialist oncologist. Even if drugs are purchased overseas, it is recommended that they be managed by doctors simultaneously in China to ensure that side effects monitoring, efficacy evaluation, combined treatment options, etc. are all under control.

Reference materials:https://www.drugs.com/